Stay updated on MCS110/BRAF/MEK Inhibition in Melanoma Clinical Trial

Sign up to get notified when there's something new on the MCS110/BRAF/MEK Inhibition in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the MCS110/BRAF/MEK Inhibition in Melanoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    A minor change updates the displayed ClinicalTrials.gov interface revision from v3.5.2 to v3.5.3, reflecting a site/version release rather than a change to the study record content.
    Difference
    0.1%
    Check dated 2026-04-24T06:08:35.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision: v3.5.2 was added to the history and Revision: v3.5.0 was removed.
    Difference
    0.1%
    Check dated 2026-04-17T02:40:10.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    39 days ago
    Change Detected
    Summary
    A new revision entry v3.5.0 was added and the previous v3.4.3 entry removed in the Record History. No substantive content changes are shown.
    Difference
    0.1%
    Check dated 2026-03-19T05:16:40.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    A new Revision: v3.4.3 was added to the record history, and the previous Revision: v3.4.2 entry was removed.
    Difference
    0.1%
    Check dated 2026-03-12T01:00:07.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; removed the previous funding/operating-status notice (Revision: v3.4.1).
    Difference
    0.7%
    Check dated 2026-02-11T11:44:44.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    Added a site-wide funding-status notice and updated the release version from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.7%
    Check dated 2026-02-04T06:34:01.000Z thumbnail image

Stay in the know with updates to MCS110/BRAF/MEK Inhibition in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the MCS110/BRAF/MEK Inhibition in Melanoma Clinical Trial page.